arginine and (dtpa-phe(1))-octreotide

arginine has been researched along with (dtpa-phe(1))-octreotide in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bakker, WH; Bernard, BF; Breeman, WA; de Jong, M; Krenning, EP; Rolleman, EJ; Visser, TJ1
de Jong, M; Kooij, PP; Krenning, EP; Rolleman, EJ; Valkema, R1

Trials

1 trial(s) available for arginine and (dtpa-phe(1))-octreotide

ArticleYear
Safe and effective inhibition of renal uptake of radiolabelled octreotide by a combination of lysine and arginine.
    European journal of nuclear medicine and molecular imaging, 2003, Volume: 30, Issue:1

    Topics: Arginine; Carcinoma, Neuroendocrine; Female; Humans; Hyperkalemia; Infusions, Intravenous; Kidney; Lysine; Neuroendocrine Tumors; Octreotide; Pentetic Acid; Radionuclide Imaging; Radiopharmaceuticals; Vomiting

2003

Other Studies

1 other study(ies) available for arginine and (dtpa-phe(1))-octreotide

ArticleYear
Inhibition of renal uptake of indium-111-DTPA-octreotide in vivo.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:8

    Topics: Acetazolamide; Animals; Arginine; Cystine; Enzyme Inhibitors; Heptanoates; Kidney; Lysine; Male; Maleates; Octreotide; Pentetic Acid; Radionuclide Imaging; Rats; Rats, Wistar; Sensitivity and Specificity; Tissue Distribution

1996